Black Rock Inc. Evolus, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,008,182 shares of EOLS stock, worth $40.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,008,182
Previous 3,260,786
22.92%
Holding current value
$40.1 Million
Previous $45.7 Million
4.74%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EOLS
# of Institutions
168Shares Held
47.8MCall Options Held
130KPut Options Held
51K-
Perceptive Advisors LLC New York, NY5.36MShares$53.6 Million2.27% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$48.5 Million6.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$32 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$28.2 Million2.72% of portfolio
-
Stonepine Capital Management, LLC Bend, OR1.37MShares$13.7 Million14.02% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $561M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...